Stiris Research Inc. completes Phase IIa Venous Leg Ulcer Study

January 16, 2020 | Stiris

London, ON – January 16, 2020 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces the completion of their Phase IIa Venous Leg Ulcer trial and that all North American sites have been soft closed and global database lock is expected in early March […]


Stiris Research Inc. Announces Collaboration With US Biotech Company On Their Neurological Movement Disorder Trial

November 6, 2019 | Stiris

Cambridge, MA – November 6, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces it has been awarded a Phase II neurological movement disorder trial. “All of us at Stiris are excited to embark on this rare movement disorder trial. Our highly experienced […]


Stiris Research Inc. announces addition of a Director, Clinical Science

May 13, 2019 | Stiris

London, ON and Cambridge, MA – May 13th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Carrie Hamilton, BSc. to the Clinical team. Carrie joins the company as the Director, Clinical Science and brings 30 years’ of biopharmaceutical experience […]


Stiris Research Inc. successful completion of their Zika Virus trial

March 6, 2019 | Stiris

London, ON – March 6, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the successfully completion of their Phase I Zika virus trial. “We are thankful to have had the opportunity to work on this exciting trial. We look forward to hearing […]


Press Release – Stiris’ Shantal Feltham Receives YMCA Women of Excellence in Entrepreneurship

February 8, 2019 | Stiris

We are pleased to announce that the President and CEO of Stiris Research, Shantal Feltham, is the recipient of the 2019 Women of Excellence Award in Entrepreneurship. This award, presented every 2 years, honours women who have contributed to the growth of their community, and whose accomplishments inspire others to achieve their goals. Shantal’s passion, […]


Stiris Research Inc. completes enrollment ahead of schedule on a Phase 1b Uveal Melanoma study

January 14, 2019 | Stiris

London, ON – January 14th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced successfully completing enrollment ahead of the Australian biotech’s corporate milestone target on their Phase 1b Open label study in Uveal Melanoma metastatic to liver. The last patient was screened […]


Stiris Research Inc. announces addition of Executive Director, Sales & Marketing

January 7, 2019 | Stiris

Cambridge, MA – January 7th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Glenn Block to its Business Development team. Glenn Block joins the company as the Executive Director, Sales & Marketing and brings 20+ years’ commercial experience in […]


Stiris Research Inc. announces favourable FDA response on US pancreatic cancer program

December 18, 2018 | Stiris

London, ON – December 18, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce that the Australian biotech they are collaborating with on a pancreatic cancer program received a favourable FDA response following review of safety data compiled for research being done in […]


Stiris Research Inc. collaborates with Canadian biotech to research a novel cancer therapy guidance tool

August 3, 2018 | Stiris

London, ON – August 3, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce it has entered into a Master Services Agreement (the “MSA”) with a Canadian biotech company for work on their international prospective clinical trial involving a novel cancer therapy guidance […]


Stiris Research Inc. announces completion of Site Closeout Visits in their Phase II Hormone Refractory Castrate-Resistant Prostate Cancer (HRCPC) study

May 24, 2018 | Stiris

London, ON – May 24, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces the completion of all 10 Closeout Visits (COVs) of North American Investigative Sites who participated in the extension phase of a Phase II Hormone-Refractory Castrate-Resistant Prostate Cancer (HRCPC) study. […]